cyproterone acetate has been researched along with Hepatocellular Carcinoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, Y; Nagasue, N; Nakamura, T; Yu, L | 1 |
| Hammerstein, J; Rabe, T; Runnebaum, B | 1 |
| Feldmann, K; Grunwald, K; Rabe, T; Runnebaum, B | 1 |
| Beckmann, J; Queisser, W; Rüdiger, T | 1 |
| Culine, S; Droz, JP; Elias, D; Kattan, J; Spatz, A; Terrier-Lacombe, MJ | 1 |
| Feldmann, K; Heinemann, L; Rabe, T; Runnebaum, B | 1 |
| Kohno, H; Kubota, H; Nagasue, N; Tachibana, M; Yamaguchi, M; Yu, L | 1 |
| Cui, Y; Fujimoto, M; Matsuo, Y; Tachibana, K; Tanae, A; Tanaka, T; Watanabe, S; Yamasaki, S | 1 |
| Regidor, M; Regidor, PA; Schindler, EM; Speer, K | 1 |
| Bonnotte, B; Chauffert, B; Gresset, AC; Lenfant, L; Lorcerie, B; Manfredi, S | 1 |
| Gaer, JA; Keane, PF; Ohri, SK | 1 |
| Forbes, A; Iqbal, MJ; Johnson, PJ; Wilkinson, ML; Williams, R | 1 |
| Schlumberger, JF | 1 |
3 review(s) available for cyproterone acetate and Hepatocellular Carcinoma
| Article | Year |
|---|---|
[Liver tumors in women using oral hormonal contraceptives].
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Humans; Hyperplasia; Liver; Liver Neoplasms; Product Surveillance, Postmarketing; Risk Factors | 1995 |
Hepatocellular carcinoma during hormonotherapy for prostatic cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cyproterone Acetate; Humans; Liver Neoplasms; Male; Neoplasms, Second Primary; Prostatic Neoplasms; Triptorelin Pamoate | 1994 |
Cyproterone acetate: is it hepato- or genotoxic?
Topics: Androgen Antagonists; Animals; Carcinoma, Hepatocellular; Cyproterone Acetate; Cytochrome P-450 Enzyme System; DNA; DNA Adducts; DNA Repair; Humans; In Vitro Techniques; Liver; Liver Neoplasms; Rats | 1996 |
1 trial(s) available for cyproterone acetate and Hepatocellular Carcinoma
| Article | Year |
|---|---|
[Long-term side-effects following cyproterone acetate containing therapy in gynecology].
Topics: Adult; Androgen Antagonists; Carcinoma, Hepatocellular; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Liver Neoplasms; Risk Factors | 2000 |
10 other study(ies) available for cyproterone acetate and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Effect of androgens and their manipulation on cell growth and androgen receptor (AR) levels in AR-positive and -negative human hepatocellular carcinomas.
Topics: Carcinoma, Hepatocellular; Cell Division; Cyproterone Acetate; Dihydrotestosterone; Humans; Liver Neoplasms; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; Testosterone; Tumor Cells, Cultured | 1995 |
[Position of the German Society of Gynecology and Obstetrics on the intended recall of approved CPA-containing drugs].
Topics: Carcinoma, Hepatocellular; Cyproterone Acetate; Drug Approval; Female; Germany; Humans; Liver Neoplasms; Product Surveillance, Postmarketing; Societies, Medical | 1995 |
Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol.
Topics: Carcinoma, Hepatocellular; Contraceptives, Oral, Combined; Cyproterone Acetate; Female; Humans; Liver Neoplasms; Middle Aged | 1995 |
Inhibition of growth and induction of TGF-beta 1 in human hepatocellular carcinoma with androgen receptor by cyproterone acetate in male nude mice.
Topics: Androgen Antagonists; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Cyproterone Acetate; DNA, Neoplasm; Humans; Immunohistochemistry; Injections, Subcutaneous; Liver Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Organ Size; Proliferating Cell Nuclear Antigen; Receptors, Androgen; Testis; Transforming Growth Factor beta; Tumor Cells, Cultured | 1996 |
Follow-up study of children with precocious puberty treated with cyproterone acetate. Ad hoc Committee for CPA.
Topics: Adenoma, Liver Cell; Adolescent; Androgen Antagonists; Carcinoma, Hepatocellular; Child; Child, Preschool; Cyproterone Acetate; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Progesterone Congeners; Puberty, Precocious; Risk | 1997 |
Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS).
Topics: Adult; Age Factors; Carcinoma, Hepatocellular; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Female; Hepatitis B; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Odds Ratio; Risk Factors; Time Factors | 1997 |
[Hepatocellular carcinoma in a healthy liver possibly due to long-term use of cyproterone acetate].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Carcinoma, Hepatocellular; Cyproterone Acetate; Drug Administration Schedule; Humans; Liver Neoplasms; Male; Time Factors | 2000 |
Hepatocellular carcinoma and treatment with cyproterone acetate.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Cyproterone; Cyproterone Acetate; Humans; Liver Neoplasms; Male; Prostatic Neoplasms | 1991 |
Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents; Carcinoma, Hepatocellular; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Female; Gonadal Steroid Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Hormone-Dependent | 1987 |
[Apropos of a letter by Mal et al.: Treatment of 25 patients with hepatocellular carcinoma with an antiandrogen, cyproterone acetate (Androcur)].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cyproterone; Cyproterone Acetate; Humans; Liver Neoplasms | 1987 |